Rein Therapeutics, Inc.
RNTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001420565
No open-market purchases or sales by Rein Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $42.3M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Rein Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +3 vs. Q4 2023
- Shares held
- 1.69M
- +624.8K (+58.7%) vs. Q4 2023
- Total value
- $11.0M
- +$7.71M (+237.9%) vs. Q4 2023
- New holders
- 4
- 6 more added
- Sold out
- 1
- 2 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $42.3M |
| Q1 2026 | 46 | $14.8M |
| Q4 2025 | 48 | $12.5M |
| Q3 2025 | 40 | $9.76M |
| Q2 2025 | 36 | $9.30M |
| Q1 2025 | 39 | $10.6M |
| Q4 2024 | 31 | $13.1M |
| Q3 2024 | 32 | $16.3M |
| Q2 2024 | 29 | $13.5M |
| Q1 2024 | 23 | $11.0M |
| Q4 2023 | 20 | $3.24M |
| Q3 2023 | 16 | $1.59M |
| Q2 2023 | 17 | $1.83M |
| Q1 2023 | 19 | $1.30M |
| Q4 2022 | 19 | $3.21M |
| Q3 2022 | 33 | $5.86M |
| Q2 2022 | 37 | $8.34M |
| Q1 2022 | 42 | $16.5M |
| Q4 2021 | 43 | $18.9M |
| Q3 2021 | 43 | $33.6M |
| Q2 2021 | 47 | $41.5M |
| Q1 2021 | 52 | $48.0M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Rein Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Acadian Asset Management LLC | 17 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 31 | $206 | 0.00% | +4+14.8% | Added |
| Game Plan Financial Advisors, LLC | 50 | $332 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 93 | $617 | 0.00% | −2,051−95.7% | Reduced |
| ICA Group Wealth Management, LLC | 100 | $663 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 125 | $829 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 233 | $1.51K | 0.00% | +183+366.0% | Added |
| US Bancorp | 1,250 | $8.29K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,250 | $8.29K | 0.00% | 00.0% | Unchanged |
| JFS Wealth Advisors, LLC | 1,590 | $10.5K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,020 | $13.4K | 0.00% | −206−9.3% | Reduced |
| Citadel Advisors LLC | 13,810 | $89.8K | 0.00% | +13,810 | New |
| Texas Capital Bank Wealth Management Services Inc | 26,171 | $173.5K | 0.02% | +10,398+65.9% | Added |
| Blair William & Co | 28,297 | $187.6K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 36,000 | $239.0K | 0.00% | +36,000 | New |
| Gagnon Securities LLC | 37,947 | $251.6K | 0.06% | 00.0% | Unchanged |
| Vanguard Group Inc | 40,314 | $267.3K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 45,064 | $299.0K | 0.00% | +17,045+60.8% | Added |
| Sigma Planning Corp | 67,985 | $450.7K | 0.01% | +51,405+310.0% | Added |
| Geode Capital Management, LLC | 69,759 | $453.4K | 0.00% | +12,471+21.8% | Added |
| Senvest Management, LLC | 230,895 | $1.30M | 0.05% | +230,895 | New |
| Nantahala Capital Management, LLC | 255,000 | $1.69M | 0.17% | +255,000 | New |
| Satter Management Co., L.P. | 830,466 | $5.51M | 5.79% | 00.0% | Unchanged |
| BlackRock Inc. | 0 | $0 | 0.00% | −189−100.0% | Sold out |